Growth Metrics

Pacific Biosciences Of California (PACB) Cash from Investing Activities Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -4,224.26%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 95.53%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 3.20%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -18.20%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -208.79%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -187.82%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -397.90%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -514.25%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -211.17%
10 Pacific Biosciences Of California 481.66 Mn 205.70 Mn 12.84 Mn -20.73%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -20.73%
Dec 31, 2025 -55.31%
Sep 30, 2025 -18.05%
Jun 30, 2025 -67.10%
Mar 31, 2025 232.51%
Dec 31, 2024 187.48%
Sep 30, 2024 -90.48%
Jun 30, 2024 177.94%
Mar 31, 2024 52.95%
Dec 31, 2023 -182.80%
Sep 30, 2023 349.51%
Jun 30, 2023 -63.55%
Mar 31, 2023 -272.53%
Dec 31, 2022 22.28%
Jun 30, 2022 86.92%
Mar 31, 2022 414.72%
Dec 31, 2021 166.76%
Jun 30, 2021 -16,017.80%
Mar 31, 2021 115.04%
Dec 31, 2020 -2,790.11%
Sep 30, 2020 -423.72%
Jun 30, 2020 -136.60%
Mar 31, 2020 -243.03%
Dec 31, 2019 38.18%
Sep 30, 2019 152.64%
Jun 30, 2019 -35.92%
Mar 31, 2019 590.18%
Dec 31, 2018 -151.62%
Sep 30, 2018 -864.78%
Jun 30, 2018 128.62%
Mar 31, 2018 -130.41%
Dec 31, 2017 60.07%
Sep 30, 2017 -55.06%
Jun 30, 2017 -364.98%
Mar 31, 2017 209.63%
Dec 31, 2016 129.75%
Sep 30, 2016 -25.41%
Jun 30, 2016 -882.91%
Mar 31, 2016 -251.91%
Dec 31, 2015 -1,386.41%
Sep 30, 2015 14.74%
Jun 30, 2015 553.63%
Mar 31, 2015 86.62%
Dec 31, 2014 93.75%
Sep 30, 2014 237.39%
Jun 30, 2014 102.51%
Mar 31, 2014 246.84%
Dec 31, 2013 -175.00%
Sep 30, 2013 -76.33%
Jun 30, 2013 -1,106.34%
Mar 31, 2013 -143.02%
Dec 31, 2012 103.82%
Sep 30, 2012 -31.11%
Jun 30, 2012 128.11%
Mar 31, 2012 143.39%
Dec 31, 2011 118.05%
Sep 30, 2011 1,019.24%